Identification of key therapeutic targets in nicotine-induced intracranial aneurysm through integrated bioinformatics and machine learning approaches.

Journal: BMC pharmacology & toxicology
PMID:

Abstract

BACKGROUND: Intracranial aneurysm (IA) is a critical cerebrovascular condition, and nicotine exposure is a known risk factor. This study delves into the toxicological mechanisms of nicotine in IA, aiming to identify key biomarkers and therapeutic targets.

Authors

  • Qiang Ma
    Department of Mechanical and Electrical Engineering, Northeast Forestry University, Harbin 150040, China.
  • Longnian Zhou
    Department of Neurosurgery II, Hexi University Affiliated Zhangye People's Hospital, No. 67 Xihuan Road, Ganzhou District, Zhangye, Gansu Province, 734000, China.
  • Zhongde Li
    Department of Neurosurgery II, Hexi University Affiliated Zhangye People's Hospital, No. 67 Xihuan Road, Ganzhou District, Zhangye, Gansu Province, 734000, China. lizhongde01231@aliyun.com.